FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:761-762 September 6, 2001 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Xiang, J. Related Article by Tillmann, H. L. PubMed Citation

Infection with the human immunodeficiency virus (HIV) is associated with conditions ranging from stability of the immune system and asymptomatic infection to severe compromise of the immune system and the development of AIDS.¹ Before highly active antiretroviral therapy became available in 1996, the usual course of events for infected persons was depletion of the CD4+ T-cell population and the development of AIDS 8 to 10 years after the initial infection. In some exceptional cases, there was a more rapid progression of disease with a brisk rate of loss of CD4+ T cells. In contrast, in other rare cases, AIDS did . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Mosier, D. E., Chisari, F. V., Macalalad, A. R., Snydman, D. R., Takamatsu, J., Toyoda, H., Fukuda, Y., Stapleton, J. T., Diekema, D. J., Xiang, J., Tillmann, H. L., Schmidt, R. E., Manns, M. P. (2002). GB Virus C and Mortality from HIV Infection. NEJM 346: 377-379 [Full Text]  
• (2001). HIV Survival: Does an Obscure Virus Make a Difference?. AIDS Clin Care 2001: 3-3 [Full Text]  
• (2001). GB Virus C: Deterrent to HIV Disease Progression?. JWatch Infect. Diseases 2001: 1-1 [Full Text]  
• (2001). Survival in AIDS: Does an Obscure Virus Make a Difference?. JWatch General 2001: 1-1 [Full Text]